About US
Contact us
-
CHMP recommends Teva’s pregnancy prevention drugThe European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the marketing authorisation of Teva Pharmaceutical's Seasonique f2014/7/9
-
GSK and Theravance announce Japanese approval for Anoro ElliptaGlaxoSmithKline (GSK) and Theravance have obtained approval from the Japanese Ministry of Health, Labour and Welfare for Anoro Ellipta to treat chronic obstructive pulmonary disease (COPD). The Japan2014/7/8
-
Forest Laboratories completes acquisition of Furiex PharmaceuticalsActavis subsidiary Forest Laboratories has completed the acquisition of Furiex Pharmaceuticals, a US-based drug development collaboration company. Forest Laboratories has acquired Furiex in an all-ca2014/7/8
-
GSK and Genmab receive European approval for ArzerraGlaxoSmithKline (GSK) and Genmab have received European Commission marketing authorisation for Arzerra as first-line treatment for chronic lymphocytic leukaemia in combination with chlorambucil or ben2014/7/7
-
FDA grants priority review designation for Boehringer’s idiopathic pulmonary fibrosis therapyThe US Food and Drug Administration (FDA) has accepted the filing of Boehringer Ingelheim Pharmaceuticals' new drug application for its nintedanib and has granted priority review designation for treat2014/7/7
-
Genentech to acquire Seragon PharmaceuticalsRoche Group member Genentech has entered into a definitive agreement to acquire the US-based biotechnology company Seragon Pharmaceuticals. Under the tagreement, Seragon Pharmaceuticals will receive2014/7/4
-
Argentina approves Genzyme’s Lemtrada for multiple sclerosisSanofi subsidiary Genzyme has received approval from the Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) for its Lemtrada (alemtuzumab) for treatment of multiple scle2014/7/4
-
Ipsen seeks US and European approvals for gastroenteropancreatic neuroendocrine tumour therapyIpsen has filed a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) for approval of its Somatuline Depot 120mg injection for treatment of gastroenteropancreatic n2014/7/3
-
Bristol-Myers Squibb receives CHMP’s positive opinion for EliquisThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorisation of Bristol-Myers Squibb and Pfizer's Eliqu2014/7/3
-
GSK and Theravance submit supplemental new drug application to FDA for asthma treatmentGlaxoSmithKline (GSK) and Theravance have submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for a fixed dose combination of fluticasone furoate and vila2014/7/2